Short answer
Cardinal Health (CAH) filed an 8-K current report with the SEC on October 1, 2026 reporting Item 7.01 (Regulation FD Disclosure). Binding letter of intent extends pharmaceutical distribution agreements with CVS Health through June 2032.
Cardinal Health 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- Binding letter of intent extends pharmaceutical distribution agreements with CVS Health through June 2032
- Long-duration CVS relationship provides visibility into Cardinal Health’s distribution revenue
- Fiscal 2027 non-GAAP EPS guidance reaffirmed at $12.40–$12.60
- Long-term non-GAAP EPS growth guidance maintained at 12%–14%
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Cardinal Health 8-K filings
Get the next CAH 8-K as it lands
Follow CAH for push alerts, or ask the research agent what this filing means.